Search

Your search keyword '"atopic dermatitis"' showing total 79,958 results

Search Constraints

Start Over You searched for: Descriptor "atopic dermatitis" Remove constraint Descriptor: "atopic dermatitis"
79,958 results on '"atopic dermatitis"'

Search Results

2. Ruxolitinib Cream in Adolescents/Adults with Atopic Dermatitis Meeting Severity Thresholds for Systemic Therapy: Exploratory Analysis of Pooled Results from Two Phase 3 Studies.

3. Practical Management of the JAK1 Inhibitor Abrocitinib for Atopic Dermatitis in Clinical Practice: Special Safety Considerations.

4. Lebrikizumab Improves Quality of Life and Patient-Reported Symptoms of Anxiety and Depression in Patients with Moderate-to-Severe Atopic Dermatitis.

5. Maintenance of Investigators Static Global Assessment Response with Once-Daily Crisaborole in Participants with Mild to Moderate Atopic Dermatitis.

6. Dermatologic Manifestations of Mitochondrial Dysfunction: A Review of the Literature.

7. Satisfaction with Control of Mild to Moderate Atopic Dermatitis with Ruxolitinib Cream: US Physician and Patient Perspectives.

8. Profiling Atopic Dermatitis Patients Using Decision Tree Classifiers to Anticipate Dupilumab Response

10. Dupilumab‐Associated Ocular Surface Disease in Pediatric Atopic Dermatitis: A Single‐Center Asian Experience.

11. Associations of multiple lifestyle behaviors with allergic disease symptoms and sensitization in 9–11-year-old Finnish children.

12. Mechanisms of autophagy and their implications in dermatological disorders.

13. Molecular mechanisms of obesity predisposes to atopic dermatitis.

14. Laboratory and clinical haemostatic aberrations in primary dermatologic disease: A review.

15. Immunoglobulin-coating patterns reveal altered humoral responses to gut bacteria in pediatric cow milk allergies.

16. Prevention of Atopic Dermatitis in Babies by Skin Care from the Newborn Period.

17. Efficacy and safety of tozorakimab in moderate‐to‐severe atopic dermatitis: A Phase 2a randomized controlled trial (FRONTIER‐2)

18. Low Infection Rates With Long‐Term Dupilumab Treatment in Patients Aged 6 Months to 5 Years: An Open‐Label Extension Study.

19. Food Allergy Test‐Guided Dietary Advice for Children With Atopic Dermatitis: A Consensus Study.

20. Long-term efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: a prospective real-world cohort study in China.

21. Transcriptomic evidence for atopic dermatitis as a systemic disease in NC/Nga mice.

22. Severe herpes simplex virus − 1 Kaposi varicelliform eruption and SARS-CoV-2 infection in atopic dermatitis treated with dupilumab.

23. Dupilumab combined with corticosteroid therapy for Kimura disease with multiple systemic masses: a case report and literature review.

24. Causal association between allergic diseases and celiac disease: a bidirectional two-sample and multivariable Mendelian-randomization study.

25. Efficacy of a Video Education Program Regarding Basic Skin Care in Pediatric Atopic Dermatitis: A Randomized Controlled Trial.

26. Pediatric Topical Steroid Withdrawal Syndrome: What Is Known, What Is Unknown.

27. A microarray‐based IgE‐molecular mimicry index (IgE‐MMI): A biomarker for disease severity, clinical phenotypes, and therapeutic response in atopic dermatitis?

28. Histamine and Th2 cytokines independently and synergistically upregulate MMP12 expression in human M2 macrophages.

29. Risk of depression in patients with atopic dermatitis: An updated systematic review and meta‐analysis of children, adolescent and adult groups.

30. Cost-Effectiveness Study of Difamilast 1% for the Treatment of Atopic Dermatitis in Adult Japanese Patients.

31. Efficacy and Safety of Ruxolitinib Cream in Atopic Dermatitis Based on Previous Medication History.

32. Systematic review of the evidence for treatment and management of common skin conditions in resource‐limited settings: An update.

33. Oclacitinib (APOQUEL®) is a selective Janus kinase 1 inhibitor with efficacy in a canine model of flea allergic dermatitis.

34. Discovery of Chemical Constituents with Anti-Atopic Dermatitis Properties from Aster koraiensis.

35. Unveiling the Impact of Moderate and Severe Atopic Dermatitis: Insights on Burden, Clinical Characteristics, and Healthcare Resource Utilization in Adult Greek Patients from the APOLO Cross-Sectional Study.

36. Amelioration of Systemic Amyloidosis by Blocking IL-17A and Not by IL-17F, and Arteriosclerosis by Blocking Both IL-17A and IL-17F in an Inflammatory Skin Mouse Model.

37. Safety and efficacy of biologic drugs in children or adolescents with atopic dermatitis: A systematic review and meta‐analysis of randomized controlled trials.

38. Childhood eczema prevalence in New Zealand using topical corticosteroid dispensing data.

39. The Association between Migration and Prevalence of Allergic Diseases: A Systematic Review and Meta-Analysis.

40. Sensitization to latex and food allergens in atopic dermatitis patients according to ALEX2 Allergy Xplorer test.

41. Reappraising the Use of Systemic Immunomodulators for Psoriasis and Eczema in the Military.

42. Inflammatory Mediators Suppress FGFR2 Expression in Human Keratinocytes to Promote Inflammation.

43. Patient Awareness, Education, and Support for Atopic Dermatitis in Egypt and Lebanon: Results of a Physician Survey and Social Analytics.

44. Eblasakimab, an Anti-IL‑13Rα1 Antibody, Reduces Atopy-Associated Serum Biomarkers in Moderate‑to‑Severe Atopic Dermatitis.

45. Exploring Genetic Association of Tea Intake With Allergic Diseases Among European Population: A Bidirectional Mendelian Randomization Study.

46. Effects of changes in daily life attributed to COVID-19 on allergic diseases among Korean adolescents.

47. The role of the skin in the atopic march.

48. The skin barrier and microbiome in infantile atopic dermatitis development: can skincare prevent onset?

49. The role of dendritic cells in the instruction of helper T cells in the allergic march.

50. Evolution of dupilumab‐associated conjunctivitis in patients with atopic dermatitis after switching dupilumab to tralokinumab or Janus kinase inhibitors (RESO‐ADOC study).

Catalog

Books, media, physical & digital resources